| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 2.436 | 5.483 | 7.113 | 3.729 | 2.173 | 1.613 | 2.834 | 4.472 |
| Total Income - EUR | - | 0 | 2.436 | 5.483 | 7.113 | 3.729 | 2.173 | 1.613 | 2.834 | 4.472 |
| Total Expenses - EUR | - | 50 | 168 | 923 | 2.115 | 1.962 | 2.048 | 1.305 | 2.812 | 2.645 |
| Gross Profit/Loss - EUR | - | -50 | 2.269 | 4.560 | 4.998 | 1.767 | 124 | 308 | 22 | 1.827 |
| Net Profit/Loss - EUR | - | -50 | 2.195 | 4.395 | 4.784 | 1.664 | 59 | 260 | 22 | 1.507 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Gaşpar Cristina- Cabinet De Boli Infecţioase S
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 156 | 0 | 0 | 0 | 17 | 51 | 51 | 848 | 442 |
| Current Assets | - | 61 | 2.233 | 6.814 | 11.262 | 12.948 | 13.209 | 7.043 | 2.708 | 1.620 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 424 | 0 | 5 | 0 | 0 | 239 | 0 |
| Cash | - | 61 | 2.233 | 6.390 | 11.262 | 12.943 | 13.209 | 7.043 | 2.469 | 1.620 |
| Shareholders Funds | - | -5 | 2.190 | 6.546 | 11.203 | 12.654 | 12.428 | 6.339 | 2.826 | 1.998 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 223 | 43 | 268 | 59 | 310 | 832 | 755 | 731 | 64 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Gaşpar Cristina- Cabinet De Boli Infecţioase Srl